Yiming Zeng

We are devoted to innovation and clinical application of interventional pulmonology, as well as systematic study on bacterial flora and its metabolites mediating target organ damage in sleep-related respiration disorder. We currently focus on the risk factors, etiology and mechanism research of chronic airway disease and stem cell-based therapy in injuried lung repair and reconstruction. We are also concerned about the application of multi-omics and precision medicine in lung cancer.